VitroGel® IKVAV High Concentration Kit (3 mL) - TWG007-2
Laminin-derived functional peptide (IKVAV) modified – tunable, xeno-free hydrogel, high concentration
choose an option and note in remarks when ordering:
VitroGel Dilution Solution TYPE1, 50 ml
VitroGel Dilution SolutionTYPE 2, 50 ml
choose an option and note in remarks when ordering:
VitroGel Dilution Solution TYPE1, 50 ml
VitroGel Dilution SolutionTYPE 2, 50 ml
Catalog #
TWG007-2
570,00 €
Verwandte Produkte
VitroGel® IKVAV High Concentration is a tunable, xeno-free (animal origin-free) hydrogel system modified with laminin-derived functional peptide (IKVAV). VitroGel IKVAV High Concentration comes with VitroGel Dilution Solution TYPE 2 (Sucrose-free formulation for cells sensitive to the sugar level in the medium) to adjust the final hydrogel strength from 10 to 4000 Pa.
| MCE Cat. No. | TWG007-2 |
|---|---|
| Datasheet URL | https://cdn.thewellbio.com/wp-content/uploads/2020/02/VitroGel-IKVAV-TDS.pdf |
| Quantity | 1KIT |
| References | Feng W, Li-ping N,Shi-feng Z, Yang L, Ze-yu W, Jing-cheng W, Xin-min F, Liang Z. Injectable Hydrogel Combined with Nucleus Pulposus-Derived Mesenchymal Stem Cells for the Treatment of Degenerative Intervertebral Disc in Rats. Hindawi. 2019. doi:10.1155/2019/8496025 Cristina B, Linda C, Anna M. F, Laura C, Ugo P, Gabriella S, Orazio F. c-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a. Cell Death and Disease. 2019;10:759. doi:10.1038/s41419-019-2003-5 Marzia D, Gustavo C, Antimo M, Gabriella C. Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells. Cancers. 2019. doi:10.3390/cancers11060784 Min X, Jun Q, Rong K, Beidi Z, Wei W, Qing Y. Synergistic effects of stromal cell-derived factor-1α and bone morphogenetic protein-2 treatment on odontogenic differentiation of human stem cells from apical papilla cultured in the VitroGel 3D system. Cell and Tissue Research. 2019. doi:10.1007/s00441-019-03045-3 Pichaya T, Xiaoyang L, Dylan D, Scott N, Francis H, Zhenfeng D. Establishment and characterization of a recurrent osteosarcoma cell line: OSA 1777. Journal of Orthopaedic Research. 2019. 10.1002/jor.24528 Li X, Seebacher NA, Xiao T, Hornicek FJ, Duan Z. Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma. J Orthop Res. 2019;37: 510–521. doi:10.1002/jor.24189 Hangzhan M, Nicole AS, Francis JH, Zhenfeng D. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma. EBioMedicine. 2019;39: 182-193. doi:org/10.1016/j.ebiom.2018.12.022 Akamandisa MP, Nie K, Nahta R, Hambardzumyan D, Castellino RC. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma. Neuro-oncology. 2019. doi:10.1093/neuonc/noz053 Huang J. 3D cell culture on VitroGel system. HSOA Journal of Cytology and Tissue Biology. 2019. DOI: 10.24966/CTB-9107/S1001 Mahauad-Fernandez WD, Okeoma CM. B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells. Sci Rep. Nature Publishing Group; 2018;8: 4305. doi:10.1038/s41598-018-22364-z Mahauad-Fernandez WD, Naushad W, Panzner TD, Bashir A, Lal G, Okeoma CM. BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells. Sci Rep. Nature Publishing Group; 2018;8: 17608. doi:10.1038/s41598-018-35710-y Seungwoo S, Jihye K, Je-Ryung L, Eun-chae J, Tae-Jin J, Wonhee L, YongKeun P. Enhancement of optical resolution in three-dimensional refractive-index tomograms of biological samples by employing micromirror-embedded coverslips. Lap Chip. 2018;18: 3484. doi: 10.1039/c8lc00880a Powell K. Adding depth to cell culture. Science. American Association for the Advancement of Science; 2017;356: 96–98. doi:10.1126/science.356.6333.96 |